Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants
Public ClinicalTrials.gov record NCT03363945. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Multi-center, Open-label, Controlled Trial to Assess the Efficacy and Safety of Cellular Immunotherapy With MDR-101 for Induction of Immune Tolerance in Recipients of HLA-matched, Living Donor Kidney Transplants
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to demonstrate the safety and efficacy of cellular immunotherapy with MDR-101 for induction of functional immune tolerance in recipients of human leukocyte antigen (HLA)-matched, living donor kidney transplants.
Study identification
- NCT ID
- NCT03363945
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 30 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 15, 2018 (Actual)
- Primary completion
- Apr 11, 2024 (Actual)
- Completion
- Apr 11, 2024 (Actual)
- Last update posted
- Jun 7, 2024
2018 – 2024
United States locations
- U.S. sites
- 18
- U.S. states
- 15
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Loma Linda University Medical Center | Loma Linda | California | 92354 | — |
| USC | Los Angeles | California | 90033 | — |
| Stanford University Medical Center | Stanford | California | 94305 | — |
| University of Colorado Denver | Aurora | Colorado | 80045 | — |
| Yale University | New Haven | Connecticut | 06519 | — |
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007 | — |
| Mayo Clinic Hospital | Jacksonville | Florida | 32224 | — |
| Loyola University Medical Center | Maywood | Illinois | 60153-3328 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| RWJBarnabas Health | Orange | New Jersey | 07052 | — |
| Upstate University Hospital | Syracuse | New York | 13210 | — |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Baylor University Medical Center | Dallas | Texas | 75246 | — |
| The Methodist Hospital | Houston | Texas | 77030 | — |
| Intermountain Transplant Center | Murray | Utah | 84107 | — |
| INOVA Fairfax Hospital | Fairfax | Virginia | 22031 | — |
| University of Wisconsin School of Medicine | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03363945, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 7, 2024 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03363945 live on ClinicalTrials.gov.